ASRC Press Releases

Self-Regulatory Unit, Prompted by Consumers, Brings Ad Tech Companies into Full Compliance with Privacy Principles

Arlington, VA – May 22, 2019 – The Online Interest-Based Advertising Accountability Program, an independent enforcer of the Digital Advertising Alliance’s self-regulatory Principles, released the results of inquiries into two advertising technology companies. These initiatives were the results of consumer complaints, which resulted in the companies, IQM Corporation and Kargo Global, Inc., updating their privacy disclosures and consumer opt-out tools to ensure that they met the requirements of industry best practices for targeted advertising, also known as interest-based...

Read More

NAD Refers Puerto Rico Telephone Company Advertising to FTC After Advertiser Declines to Participate; Claims Challenged by AT&T

New York, NY – May 21, 2019 – The National Advertising Division has referred advertising claims made by Puerto Rico Telephone Company to the Federal Trade Commission for further review after the company declined to participate in a proceeding before NAD. NAD is an investigative unit of the advertising industry’s system of self-regulation and is administered by the Council of Better Business Bureaus. Claims made by Puerto Rico Telephone Company for its Claro Wireless Service were challenged by AT&T Services, Inc.  Claims at issue included: “La Red Más Poderosa” — “Most...

Read More

NARB Recommends Doskocil Discontinue Implied Odor Reduction Claims for Cat Litter Pans, Following Van Ness Challenge

New York, NY – May 20, 2019 – A panel of the National Advertising Review Board (NARB) has found that Doskocil Manufacturing Company, Inc., doing business as Petmate, did not provide proper support for an implied odor-reduction benefit communicated by its antimicrobial protection claims for Petmate Cat Litter Pans, and recommended that such claims be discontinued.  The advertising at issue had been challenged by Van Ness Plastic Molding Company, a manufacturer of competing cat litter pans, before the National Advertising Division (NAD). The NAD is an investigative unit of the advertising...

Read More

In Response to NAD Inquiry, Maker of Vayarin Dietary Supplement Says Product has Been Discontinued and Company has Closed

New York, NY – May 13, 2019 – VAYA Pharma, Inc., the U.S. manufacturer and supplier of Vayarin, a dietary supplement marketed for the management of ADHD, has advised the National Advertising Division that the product has been discontinued and it has closed its business. NAD is an investigative unit of the advertising industry’s system of self-regulation and is administered by the Council of Better Business Bureaus. As part of NAD’s routine monitoring program, NAD requested substantiation for the following claims: “For the clinical dietary management of lipid imbalances associated...

Read More

NAD Finds “All In One” Claim Adjacent to Symptom List on Mucinex Label Not Misleading; Recommends Other Changes

New York, NY – May 13, 2019 – The National Advertising Division has found that Reckitt Benckiser, Inc.’s “All in One” claim when positioned adjacent to a list of symptoms treated by its Maximum Strength Mucinex Fast-Max Cold & Flu both on the product label and in a 30-second does not convey the misleading message that the product treats all cold and flu symptoms in one product, following a challenge by The Procter & Gamble Company, the maker of Vick’s DayQuil/Nyquil medications.  However, NAD recommended discontinuation of other challenged advertisements. NAD is an...

Read More

NARB Recommends Eli Nutrition Discontinue Certain Antacid Claims Made for TummyZen Dietary Supplement, Approves Other Claims

New York, NY – May 9, 2019 – A panel of the National Advertising Review Board (NARB) has recommended that Eli Nutrition, Inc. discontinue certain advertising claims (while also approving others) made on product packaging and in online advertising for Eli Nutrition’s TummyZen  dietary supplement.  TummyZen is an antacid containing calcium carbonate and zinc.  The advertising at issue had been challenged by GlaxoSmithKline Consumer Healthcare, L.P., which sells Tums,  before the National Advertising Division (NAD).  The NAD is an investigative unit of the advertising industry’s...

Read More